December 1, 2025 · Form 4 insider transaction
Prout Samantha bought 32,193 shares of Amicus Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest 50% on the first anniversary of the grant date and 50% on the second anniversary of the grant date, and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.